Form 4 for LGND LIGAND PHARMACEUTICALS INC
Accepted 2021-11-12 00:00:00 ET · period of report 2021-11-11 · accession 0000886163-21-000132 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-12 | 2021-11-11 | LGND | FOEHR MATTHEW W | Pres, COO | M - OptEx | $28.54 | +12.2K | 177.7K | +7% | +$347.8K |
| D | 2021-11-12 | 2021-11-11 | LGND | FOEHR MATTHEW W | Pres, COO | S - Sale+OE | $163.02 | -11.2K | 166.5K | -6% | -$1.82M |
| DM | 2021-11-12 | 2021-11-11 | LGND | FOEHR MATTHEW W | Pres, COO | M - OptEx | $0.00 | -12.2K | 24.3K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-11 | M | A | 1,028 | $100.38 | 166,525 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-11 | M | A | 11,160 | $21.92 | 177,685 | D | — | — | |
| 3 | Common | Common Stock | 2021-11-11 | S | D | 11,160 | $163.02 | 166,525 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.41 to $166.38, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Derivative | Employee Stock Option (right to buy) | 2021-11-11 | M | D | 11,160 | $0.00 | 0 | D | $21.92 · — to 2023-02-15 | 11,160 Common Stock | (F2) Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant was 02/15/13. |
| 5 | Derivative | Employee Stock Option (right to buy) | 2021-11-11 | M | D | 1,028 | $0.00 | 24,348 | D | $100.38 · — to 2027-02-24 | 1,028 Common Stock | (F3) Grant to reporting person of options to purchase shares of common stock ("Option Shares"), exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant was 02/24/2017. |